针对老年帕金森病患者用药依从性的定制干预:随机对照试验研究方案(AdhCare)
AdhCare是一项随机、对照、三盲试验,在老年帕金森病患者中比较定制干预与常规护理对用药依从性的效果,每组64人。基线及随访3、6个月时评估运动功能、生活质量和依从性。干预类型取决于不依从的主要个人原因。
要点
- AdhCare试验为随机对照三盲设计,每组64例老年帕金森病患者。
- 定制干预依据不依从的主要个人原因选择干预类型。
- 基线及随访3、6个月评估运动功能、生活质量和依从性。
核心结论
- 该研究结果将为卫生专业人员和政策制定者提供定制干预在老年帕金森病患者中有效性的有价值信息。
研究设计与样本
- 随机、对照、三盲试验,在老年帕金森病患者中测试AdhCare定制干预与常规护理相比对用药依从性的效果,每组64名参与者。
主要发现
- 研究方案未报告结果数据。
关键数值与推荐
- 干预类型取决于不依从的主要个人原因,例如忘记服药或对药物知识了解不足。
- 在基线以及随访3个月和6个月时评估运动功能、生活质量和依从性指标。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nonadherence to medication is a major issue in patients with chronic disorders such as Parkinson's disease (PD). Many interventions for increasing adherence have been tested, and these have shown weak-to-moderate efficiency. Although the best methods to improve adherence remain unclear, it is reasonable to use tailored interventions instead of the "one-size-fits-all" approach. METHODS: A randomized, controlled, triple-blinded trial in elderly patients with PD is conducted to test the efficacy of AdhCare, a tailored intervention to enhance adherence compared with that achieved with routine care (64 participants per arm). Motor function, quality of life, and adherence measures will be assessed at baseline and at 3 and 6 months of follow-up. The type of intervention depends on the main personal reason for nonadherence (e.g., forgetting to take the medication or poor knowledge about the medication). DISCUSSION: The results of this study will provide valuable information for health professionals and policymakers on the effectiveness of tailored interventions in elderly patients with PD. TRIAL REGISTRATION: German Clinical Trials Register DRKS00023655. Registered on 24 February 2021. Last update on 22 March 2023.
引用
- Mendorf S, Teschner U, Lehmann T, et al. Tailored interventions to improve adherence to medication in elderly patients with Parkinson's disease: a study protocol for a randomized controlled trial (AdhCare). Trials. 2023. PMID: 37828583. doi:10.1186/s13063-023-07663-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。